{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:31:41Z","timestamp":1789443101181,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK099412"],"award-info":[{"award-number":["DK099412"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR049610"],"award-info":[{"award-number":["AR049610"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK P30-34989"],"award-info":[{"award-number":["DK P30-34989"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Yale Rheumatic Diseases Core Center Pilot\/Feasibility Grant"],"award-info":[{"award-number":["Yale Rheumatic Diseases Core Center Pilot\/Feasibility Grant"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s10620-016-4322-z","type":"journal-article","created":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T06:47:51Z","timestamp":1475304471000},"page":"3506-3512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients"],"prefix":"10.1007","volume":"61","author":[{"given":"David N.","family":"Assis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Zeniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bucala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"key":"4322_CR1","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","volume":"382","author":"MA Heneghan","year":"2013","unstructured":"Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Autoimmune hepatitis. Lancet. 2013;382:1433\u20131444.","journal-title":"Lancet"},{"key":"4322_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","volume":"147","author":"YS de Boer","year":"2014","unstructured":"de Boer YS, van Gerven NM, Zwiers A, et al. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology. 2014;147:443\u2013452.","journal-title":"Gastroenterology"},{"key":"4322_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","volume":"139","author":"AJ Czaja","year":"2010","unstructured":"Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology. 2010;139:58\u201372.","journal-title":"Gastroenterology"},{"key":"4322_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/377068a0","volume":"377","author":"T Calandra","year":"1995","unstructured":"Calandra T, Bernhagen J, Metz CN, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 1995;377:68\u201371.","journal-title":"Nature"},{"key":"4322_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1615\/CritRevImmunol.v17.i1.30","volume":"17","author":"T Calandra","year":"1997","unstructured":"Calandra T, Bucala R. Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit Rev Immunol. 1997;17:77\u201388.","journal-title":"Crit Rev Immunol"},{"key":"4322_CR6","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1007\/s10875-012-9781-1","volume":"33","author":"R Bucala","year":"2013","unstructured":"Bucala R. MIF, MIF alleles, and prospects for therapeutic intervention in autoimmunity. J Clin Immunol. 2013;33:S72\u2013S78.","journal-title":"J Clin Immunol"},{"key":"4322_CR7","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1002\/art.30624","volume":"63","author":"A Sreih","year":"2011","unstructured":"Sreih A, Ezzeddiine R, Leng L, et al. Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. Arthritis Rheum. 2011;63:3942\u20133951.","journal-title":"Arthritis Rheum"},{"key":"4322_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cyto.2012.12.032","volume":"61","author":"MA Llamas-Covarrubias","year":"2013","unstructured":"Llamas-Covarrubias MA, Valle Y, Bucala R, et al. Macrophage migration inhibitor factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis. Cytokine. 2013;61:759\u2013765.","journal-title":"Cytokine"},{"key":"4322_CR9","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/art.22179","volume":"54","author":"SP Wu","year":"2006","unstructured":"Wu SP, Leng L, Feng Z, et al. Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma. Arthritis Rheum. 2006;54:3661\u20133669.","journal-title":"Arthritis Rheum"},{"key":"4322_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1365-2362.2001.00796.x","volume":"31","author":"H Murakami","year":"2001","unstructured":"Murakami H, Akbar SM, Matsui H, Onji M. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest. 2001;31:337\u2013343.","journal-title":"Eur J Clin Invest"},{"key":"4322_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1749-6632.2012.06735.x","volume":"1271","author":"J Nishihira","year":"2012","unstructured":"Nishihira J. Molecular function of macrophage migration inhibitory factor and a novel therapy for inflammatory bowel disease. Ann N Y Acad Sci. 2012;1271:53\u201357.","journal-title":"Ann N Y Acad Sci"},{"key":"4322_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/hep.26664","volume":"59","author":"DN Assis","year":"2014","unstructured":"Assis DN, Leng L, Du X, et al. The role of macrophage migration inhibitory factor in autoimmune liver disease. Hepatology. 2014;59:580\u2013591.","journal-title":"Hepatology"},{"key":"4322_CR13","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1093\/nar\/gni123","volume":"33","author":"XB Zhong","year":"2005","unstructured":"Zhong XB, Leng L, Beitin A, et al. Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res. 2005;33:e121.","journal-title":"Nucleic Acids Res"},{"key":"4322_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/sj.gene.6364014","volume":"4","author":"A Barton","year":"2003","unstructured":"Barton A, Lamb R, Symmons D, et al. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun. 2003;4:487\u2013491.","journal-title":"Genes Immun"},{"key":"4322_CR15","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s00467-005-1930-9","volume":"20","author":"A Berdeli","year":"2005","unstructured":"Berdeli A, Mir S, Ozkayin N, Serdaroglu E, Tabel Y, Cura A. Association of macrophage migration inhibitory factor -173C allele polymorphism with steroid resistance in children with nephrotic syndrome. Pediatr Nephrol. 2005;20:1566\u20131571.","journal-title":"Pediatr Nephrol"},{"key":"4322_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/sj.gene.6364191","volume":"6","author":"T Shimizu","year":"2005","unstructured":"Shimizu T, Hizawa N, Honda A, et al. Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata. Genes Immun. 2005;6:285\u2013289.","journal-title":"Genes Immun"},{"key":"4322_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.gene.2013.05.012","volume":"526","author":"H Zhang","year":"2013","unstructured":"Zhang H, Ma L, Dong LQ, Shu C, Xu JL. Association of the macrophage migration inhibitory factor gene\u2014173G\/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects. Gene. 2013;526:228\u2013231.","journal-title":"Gene"},{"key":"4322_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00535-003-1284-7","volume":"39","author":"H Nohara","year":"2004","unstructured":"Nohara H, Okayama N, Inoue N, et al. Association of the -173G\/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol. 2004;39:242\u2013246.","journal-title":"J Gastroenterol"},{"key":"4322_CR19","first-page":"775","volume":"25","author":"M Vivarelli","year":"2007","unstructured":"Vivarelli M, D\u2019Urbano LE, Insalaco A, et al. Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids. Clin Exp Rheumatol. 2007;25:775\u2013781.","journal-title":"Clin Exp Rheumatol"},{"key":"4322_CR20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00467-007-0729-2","volume":"23","author":"M Vivarelli","year":"2008","unstructured":"Vivarelli M, D\u2019Urbano LE, Stringini G, et al. Association of the macrophage migration inhibitory factor -173*C allele with childhood nephrotic syndrome. Pedatr Nephrol. 2008;23:743\u2013748.","journal-title":"Pedatr Nephrol"},{"key":"4322_CR21","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u2013938.","journal-title":"J Hepatol"},{"key":"4322_CR22","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.intimp.2006.06.009","volume":"6","author":"I Cvetkovic","year":"2006","unstructured":"Cvetkovic I, Stosic-Grujicic S. Neutralization of macrophage migration inhibitory factor \u2013 novel approach for the treatment of immunoinflammatory disorders. Immunopharmacol. 2006;6:1527\u20131534.","journal-title":"Immunopharmacol"},{"key":"4322_CR23","doi-asserted-by":"publisher","first-page":"7849","DOI":"10.1073\/pnas.93.15.7849","volume":"93","author":"M Bacher","year":"1996","unstructured":"Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A. 1996;93:7849\u20137854.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"4322_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.autrev.2008.07.037","volume":"8","author":"S Stosic-Gruficic","year":"2009","unstructured":"Stosic-Gruficic S, Stojanovic I, Nicoletti F. MIF in autoimmunity and novel therapeutic approaches. Autoimm Rev. 2009;8:244\u2013249.","journal-title":"Autoimm Rev."},{"key":"4322_CR25","first-page":"268","volume":"31","author":"A Foote","year":"2004","unstructured":"Foote A, Briganti EM, Kipen Y, Santos L, Leech M, Morand EF. Macrophage migration inhibitory factor in systemic lupus erythematosus. J Rheumatol. 2004;31:268\u2013273.","journal-title":"J Rheumatol"},{"key":"4322_CR26","first-page":"927","volume":"34","author":"HR Kim","year":"2007","unstructured":"Kim HR, Park MK, Cho ML, et al. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis. J Rheumatol. 2007;34:927\u2013936.","journal-title":"J Rheumatol"},{"key":"4322_CR27","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1002\/art.21285","volume":"52","author":"TR Radstake","year":"2005","unstructured":"Radstake TR, Sweep FC, Welsing P, et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 2005;52:3020\u20133029.","journal-title":"Arthritis Rheum"},{"key":"4322_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","volume":"58","author":"NM van Gerven","year":"2013","unstructured":"van Gerven NM, Verwer BJ, Witte BI, et al. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol. 2013;58:141\u2013147.","journal-title":"J Hepatol"},{"key":"4322_CR29","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12072-011-9313-8","volume":"6","author":"M Zeniya","year":"2012","unstructured":"Zeniya M, Takahashi H. Characteristics of autoimmune hepatitis in the Asia-Pacific Region: historical review. Hepatol Int. 2012;6:342\u2013349.","journal-title":"Hepatol Int."},{"key":"4322_CR30","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/ar4239","volume":"15","author":"FF Wang","year":"2013","unstructured":"Wang FF, Hugna XF, Shen N, et al. A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still\u2019s disease. Arthritis Res Ther. 2013;15:R65.","journal-title":"Arthritis Res Ther."},{"key":"4322_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/gene.2014.82","volume":"16","author":"NM van Gerven","year":"2015","unstructured":"van Gerven NM, de Boer YS, Zwiers A, et al. HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1. Genes Immun. 2015;16:247\u2013252.","journal-title":"Genes Immun"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4322-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-016-4322-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4322-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T14:35:57Z","timestamp":1589726157000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-016-4322-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["4322"],"URL":"https:\/\/doi.org\/10.1007\/s10620-016-4322-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,1]]},"assertion":[{"value":"8 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Bucala is a co-inventor on patent applications describing the utility of <i>MIF<\/i> genotype determination. The authors have no additional financial or personal conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}